Nexavar (Sorafenib) for RAF mutation please help
I need to know how good is Nexavar (Sorafenib) at targeting RAF1 mutation, I ask this because Mom used Foundation One, have this mutation, and one of three Targeted Therapies recommended is Sorafenib, the other two being Regorafenib and Trametinib
The mutation is related to cell division pathway called the MAPK path: MAPK>RAS>RAF>MEK>CCNE1
Also, how to avoid as much as we can nausea? and if you can tell the most frequent side effects in practise and ways to avoid them
Primary cancer is unknown mucinous adenocarcinoma but Sorafenib is recommended, people use it on this forum, that's why the question here
Many thanks in advance for any help
Comments
-
Just subscribed there, tryingangec said:Hello, sorry about your mom.
Hello, sorry about your mom. I am not sure about your question, however, please go to www.smartpatients.com. Join and post your questions there, they have lots of I formation about most everything. All the best!
Just subscribed there, trying to see which is the main forum to ask the question, if you can suggest one let me know
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 122.3K Cancer specific
- 2.8K Anal Cancer
- 452 Bladder Cancer
- 310 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 399 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 679 Leukemia
- 799 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 240 Multiple Myeloma
- 7.2K Ovarian Cancer
- 68 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 741 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards